Folate-Functionalized Mesoporous Hollow SnO<sub>2</sub> Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy

<div>(a) Confocal laser scanning microscopy (CLSM) images of SMMC-7721 cells treated with SFNFP for 1, 2, and 3 h, respectively. (b) The PTX concentration in SMMC-7721cells treated with pure PTX, SNFP, and SFNFP. Data represented as mean ± SD (n=3).</div>

BioMed Research International

fig6

Figure 6

Figure 6: Folate-Functionalized Mesoporous Hollow SnO<sub>2</sub> Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy 

Figure 6 | Folate-Functionalized Mesoporous Hollow SnO2 Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy 